Clinical trial
Assessment of Physical Functioning and Handling of Spiolto® Respimat® in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical Practice
NCT02720757 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Physical Functioning and Handling of Spiolto® Respimat® in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical Practice
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Terminated
- Start date
- August 26, 2016
- Completion date
- December 14, 2017
- Enrollment
- 132 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.